NFKB1 and inflammatory bowel disease: Reasonably, severe imbalances in NF-κB activity has been implicated in diseases such as inflammatory bowel disease (IBD), Crohn’s disease as well as gastrointestinal cancers (Ellis et al., 1998; Schreiber et al., 1998; Coleman and Haller, 2018).